Here is exactly what needs to be in the chart for each code type: When to Send a Physician Query Send a formal query when: High HbA1c or diabetes medications appear on record but no formal diabetes diagnosis is documented A specialist note mentions a complication but the treating physician hasnt connected it to the diabetes The type of diabetes is ambiguous (young thin patient on insulin with no Type 2 risk factors) A drug known to cause diabetes is on the medication list but no causal connection has been drawn CKD is documented but the stage is not specified Retinopathy is documented but the eye is not specified Queries must be objective
Wegovys monthly list price in the US is $1350
The strong body weight lowering effect of above GLP-1RAs, as well as the dual GIP/GLP-1 receptor agonist Tirzepatide, expanded the application of incretin-based therapeutics into the novel avenues including the anti-obesity
For GLP-1 medications, insurers may require evidence that the patient has tried other treatments or that the medication is essential for managing weight loss in the presence of other conditions like type 2 diabetes, hypertension, or cardiovascular disease
Response variability between individuals can reach 4060%, driven partly by genetic variations in GLP-1 receptor expression, GIPR sensitivity, and metabolic clearance pathways
Hence, GLP-1RAs (98) appear to be potential alternatives for the treatment of chronic pain due to their effect in reducing pain while not affecting acute injury
